Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: A histopathologic study of diagnostic validity

International Journal of Radiation Oncology Biology Physics

Volumn 50, Issue 2, 2001, Pages 317-323

  Menard, Cynthia ^a   Smith, Ian C P ^b   Somorjai, Ray L ^b   Leboldus, Leonard ^c   Patel, Rakesh ^b   Littman, Charles ^a   Robertson, Susan J ^d   Bezabeh, Tedros ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c Winnipeg Clinic   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Classifier; Magnetic resonance spectroscopy; Multivariate analysis; Prostate cancer; Radiotherapy

Indexed keywords

CELLS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLITES; RADIOTHERAPY; TISSUE; TUMORS;

MALIGNANT PROSTATE GLAND;

ONCOLOGY;

CHOLINE; CITRIC ACID; CREATINE; GLUTAMINE; LIPID;

ADULT; AGED; ALGORITHM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; METABOLISM; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE TUMOR; TECHNIQUE; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOPSY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0035370169     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01480-8     Document Type: Article

References (44)

1. Schellhammer P.F., el Mahdi A.M., Higgins E.M., et al. Prostate biopsy after definitive treatment by interstitial 125iodine implant or external beam radiation therapy. J Urol. 137:(5):1987;897-901.
2. Fuks Z., Leibel S.A., Wallner K.E., et al. The effect of local control on metastatic dissemination in carcinoma of the prostate Long-term results in patients treated with 125I implantation . Int J Radiat Oncol Biol Phys. 21:(3):1991;537-547.
3. Kaplan I.D., Prestidge B.R., Bagshaw M.A., et al. The importance of local control in the treatment of prostatic cancer. J Urol. 147:(3 Pt 2):1992;917-921.
4. Kuban D.A., el Mahdi A.M., Schellhammer P.F. Effect of local tumor control on distant metastasis and survival in prostatic adenocarcinoma. Urology. 30:(5):1987;420-426.
5. Perez C.A., Lee H.K., Georgiou A., et al. Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 26:(4):1993;581-591.
6. Cox J.D., Gallagher M.J., Hammond E.H., et al. Consensus statements on radiation therapy of prostate cancer Guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel . J Clin Oncol. 17:(4):1999;1155.
7. Hanks G.E., Hanlon A.L., Schultheiss T.E., et al. Dose escalation with 3D conformal treatment Five year outcomes, treatment optimization, and future directions . Int J Radiat Oncol Biol Phys. 41:(3):1998;501-510.
8. Pinover W.H., Hanlon A.L., Horwitz E.M., et al. Defining the appropriate radiation dose for pretreatment PSA ≤ 10 ng/mL prostate cancer. Int J Radiat Oncol Biol Phys. 47:(3):2000;649-654.
9. Valicenti R., Lu J., Pilepich M., et al. Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the Radiation Therapy Oncology Group trials. J Clin Oncol. 18:(14):2000;2740-2746.
10. Siegelman E.S. Magnetic resonance imaging of the prostate. Semin Roentgenol. 34:(4):1999;295-312.
11. Yu K.K., Scheidler J., Hricak H., et al. Prostate cancer Prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging . Radiology. 213:(2):1999;481-488.
12. 1H magnetic resonance spectra. Cancer Res. 57:(16):1997;3398-3401.
13. 1H magnetic resonance spectroscopy in the study of inflammatory bowel diseases Distinguishing ulcerative colitis from Crohn's disease . Am J Gastroenterol. 96:2001;442-448.
14. Smith I.C.P., Bezabeh T. Tissue NMR ex vivo. Young I.R. Methods in biomedical magnetic resonance imaging and spectroscopy. 2000;891-897 John Wiley, Chichester, UK.
15. 3) spatial resolution. Radiology. 198:(3):1996;795-805.
16. Garcia-Segura J.M., Sanchez-Chapado M.S., Ibarburen C., et al. In vivo proton magnetic resonance spectroscopy of diseased prostate Spectroscopic features of malignant versus benign pathology . Magn Reson Imag. 17:(5):1999;755-765.
17. Kurhanewicz J., Vigneron D.B., Hricak H., et al. Prostate cancer Metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging . Radiology. 200:(2):1996;489-496.
18. Speight J.L., Roach M. III. Imaging and radiotherapy of the prostate. Radiol Clin North Am. 38:(1):2000;159-177.
19. Zaider M., Zelefsky M.J., Lee E.K., et al. Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys. 47:(4):2000;1085-1096.
20. 31P NMR spectroscopy. J Biol Chem. 31:1987;14875-14878.
21. 1H-spectroscopy Preliminary study . Anticancer Res. 16:1996;1581-1585.
22. 1H spectra of thyroid neoplasms . Magn Reson Med. 33:1995;257-263.
23. 1H MR spectra . J Med Biochem. 3:1999;17-24.
24. Kuesel A.C., Kroft T., Saunders J.K., et al. A simple procedure for obtaining high-quality NMR spectra of semiquantitative value from small tissue specimens Cervical biopsies . Magn Reson Med. 27:1992;340-355.
25. Brawer M.K., Nagle R.B., Pitts W., et al. Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates. Cancer. 63:1989;454-460.
26. Bocking A., Aufferman W. Cytological grading of therapy-induced tumor regression in prostatic carcinoma; proposal of a new system. Diagn Cytopathol. 3:1987;108-111.
27. Consensus statement: Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology. Consensus Panel. Int J Radiat Oncol Biol Phys 1997;37(5):1035-1041.
28. Somorjai RL, Dolenko B, Nikulin A; et al. Distinguishing normal allografts from biopsy-proven rejections: Application of a three-stage classification strategy to urine MR and IR spectra. Vibrational Spectroscopy. In press.
29. Nikulin A.E., Dolenko B., Bezabeh T., et al. Near-optimal region selection for feature space reduction Novel preprocessing methods for classifying MR spectra . NMR Biomed. 11:1998;209-217.
30. Crook J., Malone S., Perry G., et al. Post radiotherapy prostate biopsies What do they really mean? Results for 498 patients . Int J Radiat Oncol Biol Phys. 48:(2):2000;355-367.
31. Crook J.M., Perry G.A., Robertson S., et al. Routine prostate biopsies following radiotherapy for prostate cancer Results for 226 patients . Urology. 45:(4):1995;524-532.
32. Scardino P.T., Wheeler T.M. Local control of prostate cancer with radiotherapy Frequency and prognostic significance of positive results of post-irradiation prostate biopsy . Natl Cancer Inst Monogr. 7:1988;95-101.
33. Kuban D.A., El-Mahdi A.M., Schellhammer P.F. The significance of post-irradiation prostate biopsy with long-term follow-up. Int J Radiat Oncol Biol Phys. 24:1992;409-414.
34. Prestidge B.R., Kaplan I., Cox R.S., et al. The clinical significance of a positive post-irradiation prostatic biopsy without metastases. Int J Radiat Oncol Biol Phys. 24:1992;403-408.
35. Bostwick D.G., Egbert B.M., Fajardo L.F. Radiation injury of the normal and neoplastic prostate. Am J Surg Pathol. 6:1982;541-551.
36. Grignon D.J., Sakr W.A. Histologic effects of radiation therapy and total androgen blockade on prostate cancer. Cancer Suppl. 75:1995;1837-1841.
37. 31P magnetic resonance spectroscopy. J Urol. 150:1993;2019-2024.
38. Costello L.C., Franklin R.B. Concepts of citrate production and secretion by prostate. II. Hormonal relationships in normal and neoplastic prostate. Prostate. 19:1991;181-205.
39. 1H magnetic resonance spectroscopy and biochemical study . Magn Reson Med. 29:1993;149-157.
40. Scheidler J., Hricak H., Vigneron D.B., et al. Prostate cancer Localization with three-dimensional proton MR spectroscopic imaging - Clinicopathologic study . Radiology. 213:1999;473-480.
41. Tedeschi G., Lundbom N., Raman R., et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas A serial proton magnetic resonance spectroscopy imaging study . J Neurosurg. 87:1997;516-524.
42. Wald L.L., Nelson S.J., Day M.R., et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg. 87:1997;525-534.
43. Kotzerke J, Prang J, Neumaier B; et al. Experience with carbon-11 choline position emission tomography in prostate carcinoma. Eur J Nucl Med 2000; Sep;27(9):1415-1419.
44. Negandank W.G., Brown T.R., Evelhoch J.L., et al. Proceedings of a National Cancer Institute Workshop MR spectroscopy and tumor cell biology . Radiology. 185:1992;875-883.